Entyvio, generically known as vedolizumab, is a prescription medication used in the treatment of certain inflammatory bowel diseases, including ulcerative colitis and Crohn's disease. It belongs to a class of drugs known as integrin receptor antagonists. Entyvio works by blocking the action of a specific protein in the body that causes inflammation, helping to reduce the symptoms of these conditions and improve the quality of life for patients. It is administered through intravenous infusion, typically at a healthcare facility, and its dosing schedule may vary depending on the individual's condition and response to treatment. As with any medication, Entyvio may have side effects, and it is important for patients to discuss their medical history and potential risks with their healthcare provider. When using ENTYVIO, a medication commonly prescribed for certain inflammatory bowel conditions, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medicine. Due to potential side effects such as headache, joint pain, nausea, and fever, which are among the more common reactions, it's important to monitor how you feel after administration. Rare but serious side effects can include allergic reactions, liver problems, and increased risk of infection, so immediate medical attention should be sought if you experience symptoms like severe rash, yellowing of the skin or eyes, or unusual tiredness. Given that ENTYVIO can cause dizziness or tiredness, driving or operating heavy machinery should be approached with caution until you know how the medication affects you. Always inform your doctor about any other medications you're taking to avoid adverse interactions. Following these precautions can help ensure the safe and effective use of ENTYVIO.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.